Showing results (111-120 of 173) with videos related to
Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
The inhibitory effect of (111)In-DTPA(0)-octreotide on intrahepatic tumor growth after partial hepatectomyGerrit D Slooter, Arend G J Aalbers, Wouter A P Breeman, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapyEric P Krenning, Roelf Valkema, Dik J Kwekkeboom, et al.Pituitary|September 27, 2006
Somatostatin receptor imaging for neuroendocrine tumorsWouter W de Herder, Dik J Kwekkeboom, Richard A Feelders, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivityWouter A P Breeman, Katy van der Wansem, Bert F Bernard, et al.Hormone Research|October 29, 2002
Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up studyInge M van der Sluis, Annemieke M Boot, Wim C Hop, et al.European Journal of Endocrinology|April 7, 2007
Diagnostic imaging of dopamine receptors in pituitary adenomasWouter W de Herder, Ambroos E M Reijs, Richard A Feelders, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 12, 2012
Tumor response assessment to treatment with [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: differential response of bone versus soft-tissue lesionsEsther I van Vliet, John J Hermans, Maria A de Ridder, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunctionArend F L Schinkel, Don Poldermans, Vittoria Rizzello, et al.Bone|October 17, 2009
Peak bone mineral density, lean body mass and fracturesAnnemieke M Boot, Maria A J de Ridder, Inge M van der Sluis, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapyWouter A P Breeman, Marion de Jong, Jack L Erion, et al.Pageof 18